Mar 22 |
MorphoSys gains after gaining U.S. antitrust approval for sale to Novartis
|
Mar 22 |
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
|
Mar 15 |
MorphoSys AG (NASDAQ:MOR) Q4 2023 Earnings Call Transcript
|
Mar 14 |
MorphoSys AG (MOR) Q4 2023 Earnings Call Transcript
|
Mar 13 |
MorphoSys GAAP EPS of €1.22, revenue of €59M
|
Mar 13 |
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
|
Mar 13 |
Earnings Scheduled For March 13, 2024
|
Mar 11 |
The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys
|
Mar 8 |
5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024
|
Mar 7 |
Invitation to MorphoSys' Full Year Results 2023 Conference Call on March 14, 2024
|